Microsaic Systems Appoint Sales and Marketing Manager
News Aug 08, 2011
Samantha joins Microsaic Systems from Uniqsis Ltd where she successfully launched and grew sales of innovative solutions to customers from the pharmaceutical industry across the USA and Europe.
Microsaic is the first and only company to have successfully miniaturised mass spectrometry (“MS”) through the development of its patented chip-based technologies (ionchip®, spraychip® and vac-chip®). The Company’s first product, the Microsaic 3500 MiD®, was launched in January 2011. It is a desktop MS system that is smaller, lighter, more energy efficient and cheaper to run than legacy conventional MS systems.
Mass spectrometry is widely accepted as a ‘gold-standard’ method for identifying chemicals. As a result, this technique is used routinely by chemists across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food and drink, healthcare and industrial chemicals.
Commenting on today’s appointment, Alan Finlay, Chief Executive of Microsaic Systems plc, said:
"We are delighted to welcome Samantha to the team. These past months have seen Microsaic Systems make good commercial and technical progress including successful product demonstrations to end-users from a broad range of markets, a growing number of engagements with sales channels and OEM partners and a resounding reception for our products and technology at ASMS 2011, the premier trade fair for our industry. In her role, Samantha will be capitalising on the interest generated so far to accelerate product introduction.”
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE